NCT05413811 2026-02-17
ACT2
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
Clinical Trials
79 trialsNCT00006436 2025-12-30
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04952766 2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4 Completed
NCT04982614 2025-08-24
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
Phase 4 Completed
NCT04544917 2025-08-13
SmartManage Stress Management for HIV+ Cancer Survivors
University of Miami
Phase NA Completed
NCT03993054 2025-06-02
C-SmartManage
University of Miami
Phase NA Completed
NCT04772469 2025-04-29
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
University of California, San Francisco
Phase NA Completed
NCT02135419 2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3 Completed
NCT03316274 2024-06-25
Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT04417946 2023-10-23
Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)
Yale University
Phase NA Completed
NCT03404297 2023-09-28
Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya
Indiana University
Phase NA Completed
NCT03304093 2023-05-12
CHIVA2
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Completed
NCT04191967 2023-01-25
Thermocoagulation for Treatment of Precancerous Cervical Lesions
University of California, San Francisco
Phase NA Completed
NCT04307433 2022-09-30
Storytelling Intervention to Promote Cervical Cancer Screening Uptakes Among Malawian Women Living With Human Immunodeficiency Virus
University of Massachusetts, Boston
Phase NA Completed
NCT02823847 2022-02-14
Non Invasive Oral Cancer Screening Among HIV Infected Individuals
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03296553 2022-01-27
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
National Institute of CancerologĂa
Phase 2 Completed
NCT02970136 2021-12-28
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Phase NA Completed
NCT00000712 2021-11-04
A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT00000758 2021-11-04
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT00000987 2021-11-04
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000996 2021-11-04
A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT00001004 2021-11-04
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT00001073 2021-11-04
Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT00001113 2021-11-04
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000658 2021-11-03
A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3 Completed
NCT00000660 2021-11-03
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000681 2021-11-03
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000687 2021-11-03
Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT00000703 2021-11-03
Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members
National Institute of Allergy and Infectious Diseases (NIAID)
Phase NA Completed
NCT00000725 2021-11-03
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000646 2021-11-02
Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000689 2021-11-02
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000694 2021-11-02
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00001114 2021-11-01
The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT00000954 2021-10-29
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000764 2021-10-28
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000769 2021-10-28
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000807 2021-10-28
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT00000626 2021-10-27
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT01441063 2020-10-27
Tocilizumab for KSHV-Associated Multicentric Castleman Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00267865 2020-06-01
Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02358226 2020-02-17
HIV & Drug Abuse Prevention for South African Men
University of California, Los Angeles
Phase 3 Completed
NCT00586339 2020-01-03
Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females
GlaxoSmithKline
Phase 2 Completed
NCT02572401 2019-10-15
STAND
University of Pennsylvania
Phase NA Completed
NCT01490359 2017-12-19
Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men
University of Pennsylvania
Phase NA Completed
NCT01843478 2017-12-12
The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling
Johns Hopkins University
Phase NA Completed
NCT02440906 2017-10-03
WIN
University of Florida
Phase NA Completed
NCT00517803 2017-08-28
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT00444379 2014-08-20
ARKS
University of California, San Francisco
Phase 4 Completed